Literature DB >> 12104075

Application of tandem mass spectrometry to biochemical genetics and newborn screening.

Kevin H Carpenter1, Veronica Wiley.   

Abstract

Tandem mass spectrometry (MS/MS) has become a key technology in the fields of biochemical genetics and newborn screening. The development of electrospray ionisation (ESI) and associated automation of sample handling and data manipulation have allowed the introduction of expanded newborn screening for disorders which feature accumulation of acylcarnitines and certain amino acids in a number of programs worldwide. In addition, the technique has proven valuable in several areas of biochemical genetics including quantification of carnitine and acylcarnitines, in vitro studies of metabolic pathways (in particular beta-oxidation), and diagnosis of peroxisomal and lysosomal disorders. This review covers some of the basic theory of MS/MS and focuses on the practical application of the technique in these two interrelated areas. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12104075     DOI: 10.1016/s0009-8981(02)00135-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

Review 1.  Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases.

Authors:  Wulf Röschinger; Bernhard Olgemöller; Ralph Fingerhut; Bernhard Liebl; Adelbert A Roscher
Journal:  Eur J Pediatr       Date:  2003-11-14       Impact factor: 3.183

Review 2.  Lysosomal storage disorders in the newborn.

Authors:  Orna Staretz-Chacham; Tess C Lang; Mary E LaMarca; Donna Krasnewich; Ellen Sidransky
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

3.  Metabolomic study on bleomycin and polyhexamethylene guanidine phosphate-induced pulmonary fibrosis mice models.

Authors:  Chan Seo; Sung-Hwan Kim; Hyeon-Seong Lee; Moongi Ji; Jeuk Min; Young-Jin Son; In-Hyeon Kim; Kyuhong Lee; Man-Jeong Paik
Journal:  Metabolomics       Date:  2019-08-17       Impact factor: 4.290

4.  Long-chain acylcarnitines activate cell stress and myokine release in C2C12 myotubes: calcium-dependent and -independent effects.

Authors:  Colin S McCoin; Trina A Knotts; Kikumi D Ono-Moore; Pieter J Oort; Sean H Adams
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-07       Impact factor: 4.310

5.  Direct Mass Spectrometry Analysis of Untreated Samples of Ultralow Amounts Using Extraction Nano-Electrospray.

Authors:  Yue Ren; Jiangjiang Liu; Linfan Li; Morgan N McLuckey; Zheng Ouyang
Journal:  Anal Methods       Date:  2013-12-07       Impact factor: 2.896

6.  Development of Flow Injection Analysis Method for the Second-Tier Estimation of Succinylacetone in Dried Blood Spot of Newborn Screening.

Authors:  Bijo Varughese; Dnyanoba Madrewar; Sunil Kumar Polipalli; Seema Kapoor
Journal:  Indian J Clin Biochem       Date:  2021-01-06

7.  Polymerase chain reaction, nuclease digestion, and mass spectrometry based assay for the trinucleotide repeat status of the fragile X mental retardation 1 gene.

Authors:  Eric D Dodds; Flora Tassone; Paul J Hagerman; Carlito B Lebrilla
Journal:  Anal Chem       Date:  2009-07-01       Impact factor: 6.986

Review 8.  Acylcarnitines--old actors auditioning for new roles in metabolic physiology.

Authors:  Colin S McCoin; Trina A Knotts; Sean H Adams
Journal:  Nat Rev Endocrinol       Date:  2015-08-25       Impact factor: 43.330

9.  Pseudo-glutarylcarnitinaemia in medium-chain acyl-CoA dehydrogenase deficiency detected by tandem mass spectrometry newborn screening.

Authors:  N Napolitano; V Wiley; J J Pitt
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

10.  Expanded newborn screening in New South Wales: missed cases.

Authors:  Jane Estrella; Bridget Wilcken; Kevin Carpenter; Kaustuv Bhattacharya; Michel Tchan; Veronica Wiley
Journal:  J Inherit Metab Dis       Date:  2014-06-27       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.